ScholarWorks@Korea University College of Medicine: Hur, Gyu Young

Detailed Information

Hur, Gyu Young (허규영)

Guro Hospital (Department of Pulmonary, Allergy, and Critical Care Medicine, Guro Hospital)

Research Area

Tel
Homepage

ResearcherID ORCiD Scopus Google Scholar ID ResearchGate

Keyword

Asthma:10||Anaphylaxis:9||asthma:8||Occupational asthma:7||COPD:7||IgE:6||Urticaria:5||Specific IgE:5||exacerbation:5||Biomarker:4||Genetic polymorphism:4||Bronchoscopy:3||Food allergy:3||allergic rhinitis:3||Nonsmall cell lung cancer:3||epidermal growth factor receptor:3||Chronic urticaria:3||Reactive oxygen species:3||EGFR:3||Prognosis:3||elderly:3||tuberculosis:3||smoking:3||Allergic rhinitis:3||MDI:3||guideline:3||Epidermal growth factor receptor:2||Chemotherapy:2||Occupational rhinitis:2||gefitinib:2||IgG:2||genetic polymorphism:2||Exercise:2||ADRB2 polymorphism:2||Aspirinintolerant asthma:2||Oxidative stress:2||Acute lung injury:2||inflammation:2||tobacco smoke:2||toluene diisocyanate:2||inhaled corticosteroid:2||Wheat:2||PTEN:2||Inflammation:2||acute exacerbation:2||leukotriene:2||Lung neoplasms:2||lung cancer:2||ACO:2||Atopy:2||anaphylaxis:2||Small cell lung cancer:2||Angioedema:2||Baker's asthma:2||Pleural effusion:2||Pneumonia:2||Intradermal skin test:2||Mortality:2||Iodinated contrast media:2||Polymorphism:2||Food hypersensitivity:2||StevensJohnson syndrome:2||Contrast Media:2||Procalcitonin:2||chronic obstructive pulmonary disease:2||Biomarkers:2||combined pulmonary fibrosis and emphysema:2||Anisakis simplex:2||Adult:2||Cross reaction:2||Gemcitabine:2||Gene polymorphism:2||Toluene diisocyanate:2||drug hypersensitivity syndrome:2||Cryotherapy:2||Leukotriene:2||eosinophil:2||epidemiology:2||regulatory T cell:2||Cysteinyl leukotriene receptor type 1:1||DLCO:1||DPspecific antibody:1||Diagnosis:1||Diffuse alveolar hemorrhage:1||Digestive enzyme:1||Dioscorea batatas:1||Drug Hypersensitivity:1||Drug allergy:1||Drug hypersensitivity syndrome:1||Drug therapy:1||Drugrelated side effects and adverse reactions:1||ECP:1||ERCC1:1||Early and late response:1||Elderly asthma:1||Eosinophil:1||Eosinophil recruitment:1||Eosinophilia:1||Eosinophils:1||Epinephrine:1||Etiology:1||Extubation:1||FCER1A:1||FCER1G:1||FEV1:1||Factor XIII:1||FcεR1β:1||FcεR1γ:1||Fibrosing mediastinitis:1||Firstline chemotherapy:1||Fish:1||Fluorouracil:1||Fooddependent exerciseinduced anaphylaxis:1||Foxp3:1||Fungal amylase:1||Fungi:1||GAP score:1||Gastric cancer:1||Gefitinib:1||Gene marker:1||Genes:1||Geographic locations:1||Gliadin:1||Goblet cell hyperplasia:1||Golytely:1||Guideline:1||HLA:1||HLA allele:1||Hamartoma:1||Heat shock protein:1||Hereditary angioedema types I and II:1||HighFlow Nasal Cannula:1||Highaffinity IgE receptor:1||Histamine:1||Histamine Nmethyltransferase:1||Hospital mortality:1||Human leukocyte antigen class:1||Hymenoptera:1||Hymenoptera venom:1||Hypersensitivity reaction:1||Hypersensitivity response:1||Hypoxemia:1||Hypoxia:1||Ikappa B kinase inhibitor:1||ICS:1||IDO:1||IL18:1||IL4:1||IL4 Receptor alpha:1||IL8:1||Idiopathic pulmonary fibrosis:1||IgA:1||IgG subclass:1||Immediate hypersensitivity reaction:1||Immigrants:1||ImmunoCAP system:1||Immunoglobulin E:1||Immunoglobulin G:1||Immunotherapy:1||Inhalant allergy:1||Inhalation exposure:1||Inhaled corticosteroids:1||Insect bites and stings:1||Interleukin18:1||Interstitial:1||Interstitial lung disease:1||Iodine:1||Irinotecan:1||Ixabepilone:1||Japanese Hop pollen:1||Kimura disease:1||Korea:1||Koreans:1||LABA:1||LAMA:1||LRRC3C:1||Late phase:1||Leucovorin:1||Leukotriene receptor antagonist:1||Leukotrienerelated genes:1||Limbic encephalitis:1||Limitedstage:1||Lipid:1||Lipid transfer protein:1||Lipopolysaccharide:1||Lipopolysaccharides:1||Long acting β2agonist:1||Longacting β2agonist:1||Lung:1||Lung cancer:1||Lung diseases:1||Lung function:1||MMP9:1||MRI Contrast Media:1||MS4A2:1||Maize:1||Mast cell:1||Mechanism:1||Mediastinal neoplasms:1||Mucus hypersecretion:1||Mulberry:1||Muscarinic antagonists:1||Muscle relaxant:1||Nasal provocation:1||Neutrophil:1||Neutrophil activation:1||Neutrophilic inflammation:1||Neutrophils:1||New sensitization:1||Nitric acid:1||NonSteroidal:1||Nonsmall cell lung carcinoma:1||Nonsmall cell lung cancer:1||Nuclear factor kappa B:1||ORMDL3:1||Occupational eosinophilic bronchitis:1||Occupational exposure:1||Older:1||Oligodeoxynucleotides:1||Opioid:1||Osteoporosis:1||Oxaliplatin:1||Oxygen:1||PGE(2):1||PPARgamma:1||Pancreatic extracts:1||Paraneoplastic syndromes:1||Parapneumonic effusion:1||Passive smoking:1||Peach:1||Perennial allergic rhinitis:1||Peripheral Tcell lymphoma:1||Pharmacogenetic:1||Phase II study:1||Platinum:1||Pneumonitis:1||Poly (ADPribose) polymerase1:1||Poly (ADPribose) polymerase1 inhibitor:1||Positive predictive value:1||Predictive marker:1||Predictor:1||Prevention:1||Prognostic factor:1||Programmed death ligand 1:1||Propylthiouracil:1||Pseudomonas aeruginosa:1||Pulmonary Disease:1||Pulmonary adenocarcinoma:1||Pulmonary edema:1||Pulmonary fibrosis:1||Pulmonary nodules:1||Pulmonary sarcomatoid carcinoma:1||Quercetin:1||ROC curve:1||Receptor:1||Registries:1||Registry:1||Reintubation:1||Remission:1||Republic of Korea:1||Respiration:1||Respiration, Artificial:1||Respiratory Distress Syndrome, Adult:1||Respiratory bronchiolitis:1||Rice allergy:1||Sanyak:1||Screening test:1||Seasons:1||Secondline therapy:1||Sensitivity:1||Sensitization:1||Serum:1||Serum total IgE:1||Severe eosinophilic asthma:1||Severity:1||Skeletalrelated event:1||Small cell lung carcinoma:1||Smoking:1||Specific IgE antibody:1||Specific IgE to Staphylococcal superantigen:1||Specific IgG:1||Specific IgG antibody:1||Specific antibody:1||Specific inhalation challenge test:1||Squalene:1||Start of any treatment until the end of radiotherapy:1||StevensJohnson Syndrome:1||Styrene:1||Superantigens:1||Superior vena cava syndrome:1||Surgery:1||Syndrome:1||TNF alpha:1||Teratoma pleural effusion:1||Therapeutics:1||Thrombophlebitis:1||Thymidylate synthase:1||Tiotropium:1||Toluene diisocyanate (TDI):1||Total IgE:1||Transglutaminase 2:1||Trauma:1||Treatment:1||Treatment outcome:1||Treatment response:1||Trigger:1||Triple therapy:1||Tuberculous pneumonia:1||Two spotted spider mite:1||Vascular endothelial growth factor:1||VentilatorInduced Lung Injury:1||Ventilatorassociated event:1||Ventilatorassociated pneumonia:1||Ventilatorinduced lung injury:1||Ventilators:1||Vinorelbine:1||Wheat Flour:1||Wild type:1||acute exacerbation of COPD:1||adult:1||air pollution:1||air quality index:1||allergen:1||allergen immunotherapy:1||antihistamine, treatment:1||anxiety:1||artificial:1||aspiration pneumonia:1||aspirin hypersensitivity:1||asthma exacerbation:1||asthma, occupational:1||asthmalike symptoms:1||bacterial infection:1||bacterium:1||baker's asthma:1||basophil activation:1||biological markers:1||biological variation:1||biomarker:1||cardiovascular diseases:1||chromosome 17q21:1||chronic urticaria:1||club cell secretory protein16:1||comorbidity:1||componentresolved diagnosis:1||cyclosporine:1||depression:1||deterioration:1||disease management:1||disease outbreaks:1||drug allergy:1||drug reaction with eosinophilia and systemic symptoms:1||embolization:1||epidermal growth factor:1||epithelium:1||evidence:1||evidencebased medicine:1||ferritin:1||food allergy:1||fungating mass:1||gene polymorphisms:1||haemangioma:1||haplotype:1||histamine release:1||histological type:1||house dust mite:1||immune tolerance:1||immunotherapy:1||indoleamine2:1||interleukin (IL)6:1||interleukin10:1||interleukin27:1||isocyanates:1||isoniazid:1||leukotriene receptor antagonist:1||levodropropizine:1||low density lipoprotein receptorrelated protein2:1||lung function tests:1||lung injury:1||mRNA stability:1||malignant mesothelioma:1||manifestation:1||mass screening:1||mechanical:1||mechanical ventilators:1||mediastinum:1||medication adherence:1||metabolic syndrome:1||metabolomics:1||metalloproteinase inhibitor:1||microbial sensitivity tests:1||mortality:1||mucin:1||mucins:1||multicenter study:1||multiple sites:1||nasal provocation:1||neoplasm staging:1||neutrophil:1||nitric oxide:1||nonsmall cell lung carcinoma:1||nonsmallcell lung carcinoma:1||occupational asthma:1||older:1||oral provocation test:1||outcome:1||particulate matter:1||pharmacoepidemiology:1||phosphatase and tensin homolog deleted on chromosome 10:1||physical activity:1||posttraumatic:1||predictors:1||prognostic factors:1||proteome:1||protooncogene proteins cakt:1||psychological distress:1||readmission:1||rebamipide:1||receptor, epidermal growth factor:1||reference values:1||rifampin:1||rosiglitazone:1||rosigtitazone:1||secondline treatment:1||serious outcomes:1||severe cutaneous adverse reactions:1||severity:1||single nucleotide polymorphism:1||skin:1||specific IgE:1||specific IgG:1||specific IgG antibody:1||specific immunoglobulin E:1||statin:1||stress disorders:1||sublingual immunotherapy:1||survey:1||swine diseases:1||symptom assessment:1||therapeutics:1||toxic epidermal necrolysis:1||transferrin:1||transforming growth factor beta 1:1||transforming growth factorbeta:1||transglutaminase:1||trichinellosis:1||urinary Lhistidine:1||vascular endothelial growth factor (VEGF):1||vascular endothelial growth factorA:1||virus:1||viruses:1||vitamin Dbinding protein:1||workrelated symptom:1||β2adrenergic receptor polymorphism:1||알레르기비염:1||질산:1||천식:1||치료:1||0:1||화학성 폐렴:1||1:1||1phosphatidylinositol 3kinase:1||1st line therapy:1||3dioxygenase:1||ANCA:1||ARDS:1||ASA hypersensitivity:1||ASAintolerant acute urticaria:1||Acute Lung Injury:1||Acute exacerbation:1||Adenoid:1||Adverse Reactions:1||Airway remodeling:1||Allergen:1||Allergen immunotherapy:1||Alternaria:1||Amoxicillin:1||Anaplastic large cell lymphoma:1||AntiInflammatory Agents:1||Antigen challenge:1||Antihistamine drugs:1||Antitubercular agents:1||Apitherapy:1||Apoptosis:1||Asian patients:1||Aspirin:1||Aspirin hypersensitivity:1||Aspirin sensitivity:1||Aspirinintolerant:1||Aspirinintolerant chronic urticaria:1||Asthma control:1||AsthmaCOPD overlap:1||Autoantibody:1||BAL:1||Bacteria:1||Bacterial:1||Basophil histamine release test:1||Bee pollen:1||Bee venom:1||Bee venoms:1||Beef allergy:1||Biodiastase:1||Biologic markers:1||Biologics:1||Bone Mineral Density:1||Bone metastases:1||Bovine serum albumin:1||Bronchial asthma:1||Bronchial hyperreactivity:1||Bronchial neoplasms:1||Bronchiectasis:1||Bronchoalveolar lavage fluid:1||Bronchodilating effect:1||CerbB2:1||Creactive protein:1||COX2:1||CRTH2:1||Cannula:1||Carcinoid tumor:1||Cardiac Dysfunction:1||Chemoradiotherapy:1||Children:1||Chronic Obstructive:1||Chronic bronchitis:1||Chronic obstructive pulmonary disease:1||Chronic urticaria patients with aspirin hypersensitivity:1||Cisplatin:1||Coccidioidomycosis:1||Codeine:1||Codonopsis lanceolata:1||Cognitive function:1||Comorbidity:1||Complement C1s esterase inhibitor proteins:1||Control:1||Cough:1||Cow's milk allergy:1||Crossallergenicity:1||Cysteinyl leukotriene receptor 1:1||

STATISTICS: Total View :12,764,747; Today View :48,918

RSS_1.0 RSS_2.0 ATOM_1.0

73, Goryeodae-ro, Seongbuk-gu, Seoul, Republic of Korea (02841)82-2-2286-1265

Certain data included herein are derived from the © Web of Science of Clarivate Analytics. All rights reserved.
You may not copy or re-distribute this material in whole or in part without the prior written consent of Clarivate Analytics.

Detailed Information

Keyword

BROWSE